PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - High Risk and Nested Registry 7

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 583 participants.

Also called NCT03222141

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 583 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03222141
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03222141. Allocation not applicable; no masking; primary purpose treatment. Start 2013-10 (actual); primary completion 2015-09 (actual). Results posted on 2018-08-14.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - High Risk and Nested Registry 7
Acronym
PII S3HR/NR7
Condition
Symptomatic Severe Aortic Stenosis
Intervention (Device)
TAVR Implantation of the THV Prosthesis
Lead sponsor
Edwards Lifesciences (class: industry)

Record details

Record id
cardio:ct-nct03222141
Content hash
a628780faf7f93c961d73d318c54e9f7e564903f4ba782708f368beb679fba66